Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas
- 385 Downloads
The purpose of this investigation was to evaluate the effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drop through freshly excised goat, sheep, and buffalo corneas. Aqueous isotonic ophthalmic solutions of moxifloxacin hydrochloride of different concentrations (pH 7.2) or 0.5% (wt/vol) solutions of different pH or 0.5% solutions (pH 7.2) containing different preservatives were made. Permeation characteristics of drug were evaluated by putting 1 mL formulation on freshly excised cornea (0.50 cm2) fixed between donor and receptor compartments of an all-glass modified Franz diffusion cell and measuring the drug permeated in the receptor (containing 10 mL bicarbonate ringer at 37°C under stirring) by spectrophotometry at 291 nm, after 120 minutes. Statistical analysis was done by one-way analysis of variance (ANOVA) followed by Dunnett’s test. Increase in drug concentration in the formulation resulted in an increase in the quantity permeated but a decrease in percentage permeation. Increase in pH of the solution from 5.5 to 7.2 increased drug permeation, indicating pH-dependent transport. Compared with control formulation, moxifloxacin 0.5% (wt/vol) solution (pH 7.2) containing disodium edetate (EDTA) (0.01% wt/vol) produced significantly (P<.05) higher permeation with all the corneas. Formulation with benzyl alcohol significantly (P<.05) increased permeation with buffalo cornea compared with its control. Presence of benzalkonium chloride (BAK) (0.01% wt/vol) and EDTA (0.01% wt/vol) in the formulation increased permeation to the maximum with all the corneas. The results suggest that moxifloxacin 0.5% ophthalmic solution (pH 7.2) containing BAK (0.01%) and EDTA (0.01%) provides increased in vitro ocular availability through goat, sheep, and buffalo corneas.
Keywordsmoxifloxacin concentration pH preservative cornea permeation
- 1.Hardman JG, Limbird LE. Goodman & Gillman’s The Pharmacological Basis of Therapeutics. New York, NY: McGraw-Hill; 2001.Google Scholar
- 15.Maurice DM, Riley MV. Ocular Pharmacokinetics. In: Graymore CN, ed. Biochemistry of the Eye. London, UK: Academic Press; 1970:6–16.Google Scholar
- 22.Hecht G, Roehrs RE, Cooper ER, Hiddeman JW, Van Duzee BF. Evaluation of Ophthalmic Pharmaceutical Products., In: Banker GS, Rhodes CT, eds. Modern, Pharmaceutics, Vol 40. New York, NY: Marcel Dekker; 1990:539–603.Google Scholar